LEXICON PHARMACEUTICALS, INC. Deferred Income Tax Expense (Benefit)
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2023-03-03
- LEXICON PHARMACEUTICALS, INC. deferred income tax expense (benefit) for the quarter ending 2020-12-31 was $0.00.
- LEXICON PHARMACEUTICALS, INC. deferred income tax expense (benefit) for the quarter ending 2019-12-31 was $0.00.
- LEXICON PHARMACEUTICALS, INC. deferred income tax expense (benefit) for the quarter ending 2018-12-31 was $0.00.
- LEXICON PHARMACEUTICALS, INC. deferred income tax expense (benefit) for the quarter ending 2018-09-30 was $0.00.
- LEXICON PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2022 was $0.00.
- LEXICON PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2021 was $0.00.
- LEXICON PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2020 was $0.00.
- LEXICON PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2019 was -$6.01M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-03 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-03 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $0.00 10-K · filed 2023-03-03 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-10-30 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$6.01M 10-K · filed 2022-03-10 | |||
| 2019-09-30 | -$6.01M 10-Q · filed 2020-10-30 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $0.00 10-K · filed 2021-03-12 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | -$4.01M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $0.00 10-Q · filed 2018-07-30 | -$4.01M derived: sum of 3 quarters · filed 2020-03-12 | -$4.01M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-03 | -$4.01M derived: sum of 2 quarters · filed 2020-03-12 | -$4.01M derived: sum of 3 quarters · filed 2020-03-12 | -$4.01M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | -$4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$4.01M derived: sum of 2 quarters · filed 2020-03-12 | -$4.01M derived: sum of 3 quarters · filed 2020-03-12 | -$12.66M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | -$8.65M 10-Q · filed 2018-11-01 | -$8.65M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-01 | -$8.65M 10-Q · filed 2018-07-30 | -$8.65M derived: sum of 3 quarters · filed 2019-03-15 | -$8.65M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-03-31 | -$8.65M 10-Q · filed 2018-05-03 | -$8.65M derived: sum of 2 quarters · filed 2019-03-15 | -$8.65M derived: sum of 3 quarters · filed 2019-03-15 | -$8.65M derived: sum of 4 quarters · filed 2019-03-15 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-15 | $0.00 derived: sum of 3 quarters · filed 2019-03-15 | $0.00 10-K · filed 2019-03-15 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-01 | $0.00 10-Q · filed 2017-08-01 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 | ||||
| 2014-12-31 | -$70.00K 10-K · filed 2017-03-06 | $70.00K 10-K · filed 2015-03-12 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |